PS
Parag Shah
About Parag Shah
Data last updated:
Parag Shah is a Director at Myra Foils Private Limited (since 2019), Designated Partner at Coral Meditech Llp (since 2025) and Director at Primeus Biolabs Private Limited (since 2024). The companies operate in Packaging. The largest current company by reported revenue is Myra Foils Private Limited at ₹58.22 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Jan 2019 | 2019 | ₹58.22 Cr (FY 2025) | Active | |
| Designated Partner | 22 May 2025 | 2025 | Active | ||
| Director | 11 Sep 2024 | 2024 | Active |
Board colleagues of Parag Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhawal Shah | 08317955 | Myra Foils Private Limited | Director |
| Ashutosh Goyal | 06719970 | Coral Meditech Llp | Designated Partner |
| Pankaj Dua | 11119677 | Coral Meditech Llp | Designated Partner |
| Prateek Goyal | 06719963 | Coral Meditech Llp | Designated Partner |
| Vasu Jindal | 09700566 | Primeus Biolabs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Parag Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parag Shah
Parag Shah currently holds 3 directorships: Myra Foils Private Limited (Director, since 02 Jan 2019, revenue ₹58.22 Cr (FY 2025)); Coral Meditech Llp (Designated Partner, since 22 May 2025); Primeus Biolabs Private Limited (Director, since 11 Sep 2024).
Parag Shah was first appointed on 02 Jan 2019 as Director at Myra Foils Private Limited. The most recent appointment on record is 22 May 2025 at Coral Meditech Llp.
The current boards of Parag Shah's companies include Dhawal Shah (Myra Foils Private Limited), Ashutosh Goyal (Coral Meditech Llp), Pankaj Dua (Coral Meditech Llp), Prateek Goyal (Coral Meditech Llp), Vasu Jindal (Primeus Biolabs Private Limited).